Navigation Links
New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
Date:5/30/2013

San Diego, CA (PRWEB) May 30, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and it is now actively providing expert opinion in view of the recent news on Granuflo Lawsuits.

According to court documents, on May 17, 2013 a daughter filed a lawsuit in Massachusetts District Court (case no. 1:2013cv11215) alleging that her mother suffered a fatal cardiac arrest caused by Granuflo and Naturalyte dialysis treatments. Granuflo, manufactured by Fresenius Medical Care, is an additive used in kidney dialysis to help patients maintain their bicarbonate levels which neutralize the acid buildup in the bloodstream during dialysis.

On April 23, 2013 the children of a woman filed a lawsuit in Louisiana Western District Court (case no. 5:2013cv00829) alleging that their mother died as a result of using Granuflo and NaturaLyte. In the lawsuit plaintiffs claim that, during hemodialysis at a Fresenius medical center, their mother suffered a cardiac event and she died of a heart attack a few hours later.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Granuflo severe complications. Sean Burke, director of Media Relations at AttorneyOne.com, adds that the relevant information illustrates that people continue to file Granuflo lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

Court data updated on May 14, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), indicate that there are 161 actions pending in the Granuflo/Naturalyte MDL (MDL 2428, U.S. District Court for the District of Massachusetts). All the actions in the MDL involve similar allegations that plaintiffs suffered injury or death caused by the use of GranuFlo and/or NaturaLyte during hemodialysis, which allegedly may cause metabolic alkalosis in patients resulting in low blood pressure, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest.

AttorneyOne.com has further information on Granuflo lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/5/prweb10773984.htm

Read the full story at http://www.prweb.com/releases/2013/5/prweb10783818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
5. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
6. Grant funds cardiac stem cell research for Duchenne muscular dystrophy-related heart disease
7. Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles
8. Study suggests new role for ECMO in treating patients with cardiac arrest and profound shock
9. Estrogen Levels Tied to Risk for Sudden Cardiac Death in Study
10. Study finds survival from cardiac arrest highest in the operating room or post-anesthesia care unit
11. Common Heart Meds May Boost Recovery From Non-Cardiac Surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... introducing the Aerolib Learning Management System: an On-demand E-learning system for Clinical ... and Hospital Administration that is based on Aerolib`s successful education methodology of ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... SF expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, ... growing demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... 2017 , ... This month, the CEO and Clinical Director of Sober Living ... center in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO ... Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed ...
(Date:1/19/2017)... ... 19, 2017 , ... WhoHaha , a digital media company dedicated to ... (AHA) to produce a three-part video series that uses humor to highlight ways to ... launch of AHA’s Healthy For Good™ movement, which is designed to inspire all Americans ...
(Date:1/19/2017)... ... 2017 , ... Cosmetic Town, an online plastic surgery community, begins 2017 with ... easier for their readers to get the information they desire. The procedures are now ... techniques used on those particular areas. , “We are excited to streamline our listings ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , , Marks E-QURE , ... agreement, following similar agreements in Israel and ... 5 billion global market ... leader in medical devices for the treatment of advanced wound care, announced today ... in Colombia for the Company,s patented Bio-electrical Signal Therapy ...
(Date:1/19/2017)... Jan. 18, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: